Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
Not yet recruiting · NCT06696131 · Registry updated 2026-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH) | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 1 | 2026-04-30 | NCT06696131 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gaurav Gupta, MD | 1 |
| Genentech, Inc. | 221 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||